The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Hypocretin (orexin) loss in Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Self-citationMignot, E., Lammers, G. J., Ripley, B., Okun, M., Nevsimalova, S., Overeem, S., Vankova, J., Black, J., Harsh, J., Bassetti, C., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1553 · Cited by 1,126
Self-citationDistribution of orexin neurons in the adult rat brain
Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M., & Goto, K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01336-0 · Cited by 1,068
Staging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · cited 1×
“For all cases, the clinical diagnosis was verified by a systematic neuropathological examination according to van de Nes et al. and Braak et al. (Braak et al., 1993; van de Nes et al., 1998).”
MethodAlterations in the circadian rest-activity rhythm in aging and Alzheimer's disease
Witting, W., Kwa, I. H., Eikelenboom, P., Mirmiran, M., & Swaab, D. F. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90523-5 · Cited by 621
Self-citationHypocretin (orexin) cell loss in Parkinson's disease
Thannickal, T. C., Lai, Y.-Y., & Siegel, J. M. (2007) · Brain · doi:10.1093/brain/awm097 · Cited by 566
Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord
van den Pol, A. N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03171.1999 · Cited by 526
Hypocretin (orexin) loss in Parkinson's disease
Fronczek, R., Overeem, S., Lee, S. Y. Y., Hegeman, I. M., van Pelt, J., van Duinen, S. G., Lammers, G. J., & Swaab, D. F. (2007) · Brain · doi:10.1093/brain/awm090 · Cited by 463
Self-citationCSF hypocretin/orexin levels in narcolepsy and other neurological conditions
Ripley, B., Overeem, S., Fujiki, N., Nevsimalova, S., Uchino, M., Yesavage, J., Di Monte, D., Dohi, K., Melberg, A., Lammers, G. J., et al. (2001) · Neurology · doi:10.1212/wnl.57.12.2253 · Cited by 415
Self-citationSleep Problems and Institutionalization of the Elderly
Pollak, C. P., & Perlick, D. (1991) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879100400405 · Cited by 395
Narcolepsy:Clinical Features, New Pathophysiologic Insights, and Future Perspectives
Overeem, S., Mignot, E., GertvanDijk, J., & Lammers, G. J. (2001) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200103000-00002 · Cited by 333
Self-citationNocturnal sleep of narcoleptics
Rechtschaffen, A., Wolpert, E. A., dament, W. C., Mitchell, S. A., & Fisher, C. (1963) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(63)90032-4 · Cited by 301
Sleep disorders in Alzheimer's disease and other dementias
Bliwise, D. L. (2004) · Clinical Cornerstone · doi:10.1016/s1098-3597(04)90014-2 · Cited by 272
Localized Loss of Hypocretin (Orexin) Cells in Narcolepsy Without Cataplexy
Thannickal, T. C., Nienhuis, R., & Siegel, J. M. (2009) · Sleep · doi:10.1093/sleep/32.8.993 · Cited by 267
Hypocretin (OREXIN): Role in Normal Behavior and Neuropathology
Siegel, J. M. (2004) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.141545 · Cited by 246
Characteristics of Sleep Disturbance in Community-Dwelling Alzheimer's Disease Patients
McCurry, S. M., Logsdon, R. G., Teri, L., Gibbons, L. E., Kukull, W. A., Bowen, J. D., McCormick, W. C., & Larson, E. B. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200203 · Cited by 246
Wu, Y., Fischer, D. F., Kalsbeek, A., Garidou‐Boof, M., van der Vliet, J., van Heijningen, C., Liu, R., Zhou, J., Swaab, D. F., Wu, Y., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4446fje · Cited by 175
Self-citationTractenberg, R. E., Singer, C. M., Cummings, J. L., & Thal, L. J. (2003) · Journal of Sleep Research · doi:10.1046/j.0962-1105.2003.00374.x · Cited by 174
Relationship between CSF hypocretin levels and hypocretin neuronal loss
Gerashchenko, D., Murillo‐Rodríguez, E., Lin, L., Xu, M., Hallett, L., Nishino, S., Mignot, E. J.-M., & Shiromani, P. J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00388-1 · Cited by 163
Hypocretin and Melanin‐Concentrating Hormone in Patients with Huntington Disease
Aziz, N. A., Fronczek, R., Maat–Schieman, M. L. C., Unmehopa, U. A., Roelandse, F. W. C., Overeem, S., van Duinen, S. G., Lammers, G. J., Swaab, D. F., & Roos, R. A. C. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00135.x · Cited by 128
Self-citationGoldstone, A. P., Unmehopa, U. A., Bloom, S. R., & Swaab, D. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8230 · Cited by 120
Self-citationvan de Nes, J. A. P., Kamphorst, W., Ravid, R., & Swaab, D. F. (1998) · Acta Neuropathologica · doi:10.1007/s004010050872 · Cited by 106
Self-citationThe Number of Hypothalamic Hypocretin (Orexin) Neurons Is Not Affected in Prader-Willi Syndrome
Fronczek, R., Lammers, G. J., Balesar, R. A., Unmehopa, U. A., & Swaab, D. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0296 · Cited by 105
Self-citationMirmiran, M., Swaab, D. F., Kok, J. H., Hofman, M. A., Witting, W., & van Gool, W. A. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64570-7 · Cited by 102
Self-citationFung, S. J., Yamuy, J., Sampogna, S. L., Morales, F. R., & Chase, M. H. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02318-6 · Cited by 95
REM latency in Alzheimer's disease
Bliwise, D. L., Tinklenberg, J. R., Yesavage, J. A., Davies, H. D., Pursley, A. M., Petta, D., Widrow, L., Guilleminault, C., Zarcone, V. P., & Dement, W. C. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90179-0 · Cited by 92
Presenile dementia syndromes: an update on taxonomy and diagnosis
Greicius, M. D., Geschwind, M. D., & Miller, B. L. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.691 · Cited by 90
Hypocretin/orexin disturbances in neurological disorders
Fronczek, R., Baumann, C. R., Lammers, G. J., Bassetti, C. L., & Overeem, S. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2008.05.002 · Cited by 72
Self-citationREM sleep changes in rats induced by siRNA‐mediated orexin knockdown
Chen, L., Thakkar, M. M., Winston, S. H., Bolortuya, Y., Basheer, R., & McCarley, R. W. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05058.x · Cited by 71
Alzheimer Disease and Its Management: A Review
Samanta, M. K., Wilson, B., Santhi, K., Kumar, K. P. S., & Suresh, B. (2006) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000208274.80496.f1 · Cited by 65
In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1
Friedman, L., Zeitzer, J. M., Lin, L., Hoff, D., Mignot, E. J.-M., Peskind, E. R., & Yesavage, J. A. (2007) · Neurology · doi:10.1212/01.wnl.0000256731.57544.f9 · Cited by 61
Cited by
Roh, J. H., Huang, Y., Bero, A. W., Kasten, T., Stewart, F. R., Bateman, R. J., & Holtzman, D. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004291 · Cited by 563
Mander, B. A., Winer, J. R., Jagust, W. J., & Walker, M. P. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.05.002 · Cited by 471
Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
Liguori, C., Romigi, A., Nuccetelli, M., Zannino, S., Sancesario, G., Martorana, A., Albanese, M., Mercuri, N. B., Izzi, F., Bernardini, S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2510 · Cited by 352
Lyra e Silva, N. M., Gonçalves, R. A., Pascoal, T. A., Lima-Filho, R. A. S., Resende, E. D. P. F., Vieira, E. L. M., Teixeira, A. L., de Souza, L. C., Peny, J. A., Fortuna, J. T. S., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01349-z · Cited by 347
Clarke, J. R., Lyra e Silva, N. M., Figueiredo, C. P., Frozza, R. L., Ledo, J. H., Beckman, D., Katashima, C. K., Razolli, D., Carvalho, B. M., Frazão, R., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404183 · Cited by 214
“More recently, voxel-based morphometry analysis showed reduced hypothalamic volume and a decreased number of orexin neurons in AD patients compared to healthy controls (Loskutova et al, 2010; Fronczek et al, 2012).”
Background
Metadata
- Authors
- Fronczek, R., van Geest, S., Frölich, M., Overeem, S., Roelandse, F. W. C., Lammers, G. J., & Swaab, D. F.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 33
- Issue
- 8
- Pages
- 1642-1650
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2024830095
- Cited by
- 254
- References
- 32
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.